Sera Prognostics (SERA) Depreciation & Amortization (CF) (2020 - 2026)
Sera Prognostics (SERA) posted Depreciation & Amortization (CF) of $193000.0 for Q1 2026, down 20.9% on a QoQ basis from $244000.0 in Q4 2025, and down 10.65% year-over-year from $216000.0 in Q1 2025.
Sera Prognostics (SERA) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Sera Prognostics' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $193000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 10.65% year-over-year to $193000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $917000.0 (up 10.88% YoY) and the FY2025 annual result came in at $940000.0, up 12.85% from the prior year.
- Depreciation & Amortization (CF) was $193000.0 for Q1 2026 at Sera Prognostics, down from $244000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $244000.0 in Q4 2025 and bottomed at $193000.0 in Q1 2026.
- A 5-year average of $212117.6 and a median of $200000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 100.0% — and 2026, when it dropped 10.65%.
- Sera Prognostics' Depreciation & Amortization (CF) stood at $200000.0 in 2022, then increased by 6.0% to $212000.0 in 2023, then retreated by 0.47% to $211000.0 in 2024, then rose by 15.64% to $244000.0 in 2025, then retreated by 20.9% to $193000.0 in 2026.
- Business Quant data shows SERA's Depreciation & Amortization (CF) at $193000.0 in Q1 2026, $244000.0 in Q4 2025, and $243000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 108.71 Bn | 99.49 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 48.59 Bn | 44.92 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 28.40 Bn | 27.29 Bn | 750.30 Mn | 67.10 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 78.00 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.37 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Sera Prognostics | 107.05 Mn | 107.05 Mn | -28,000.00 | 193,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193,000.00 |
| Mar 31, 2026 | 193,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Sep 30, 2025 | 243,000.00 |
| Sep 30, 2025 | 243,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | 216,000.00 |
| Mar 31, 2025 | 216,000.00 |
| Dec 31, 2024 | 211,000.00 |
| Dec 31, 2024 | 211,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 213,000.00 |
| Mar 31, 2024 | 213,000.00 |
| Dec 31, 2023 | 212,000.00 |
| Dec 31, 2023 | 212,000.00 |